Complete Side Effects Guide
Semaglutide Side Effects: What to Expect
Semaglutide is sold under three brand names: Ozempic (diabetes), Wegovy (weight loss), and Rybelsus (oral diabetes). Here's what the STEP and SUSTAIN clinical trial data actually shows about side effects, how long they last, and what to do about them.
16-44%
Nausea, Ozempic 0.5 mg to Wegovy 2.4 mg
4-8 wks
Until Symptoms Improve
Mild
Most Side Effects
GI
Primary Category
Ozempic
Injectable for type 2 diabetes. Weekly injection.
Wegovy
Injectable for weight loss. Higher doses available.
Rybelsus
Oral tablet for type 2 diabetes. Daily pill.
Most Common Side Effects
Data from the STEP (weight loss) and SUSTAIN (diabetes) trials shows the most common semaglutide side effects are gastrointestinal. They get worse at higher doses and usually get better as your body adapts.
💡 Note: Wegovy is dosed higher for weight loss (2.4mg recommended maintenance, up to a 7.2mg maximum) than Ozempic for diabetes (up to 2mg), and its label rates are higher. The two labels come from different trial populations with different placebo rates (nausea 16% vs 6.1%), so dose alone does not explain the gap.
Why GI Side Effects Happen
The GI symptoms aren't random. They're a direct consequence of how semaglutide works:
Delayed Gastric Emptying
Food stays in your stomach longer, causing fullness and nausea.
Brain Appetite Centers
GLP-1 receptors in the brain reduce appetite but can trigger nausea.
Gut Receptor Activation
GLP-1 receptors throughout the GI tract affect motility and secretion.
When Do Side Effects Improve?
Side effects follow a fairly predictable pattern:
Week 1-2
Side effects most noticeable, especially nausea. This is normal.
Week 3-4
Symptoms begin to decrease as your body adjusts.
Week 6+
Most people report symptoms have largely resolved or become very mild.
Dose Escalation
Side effects may briefly return but are usually milder.
💡 Pro tip: The gradual dose escalation schedule (starting at 0.25mg) exists specifically to minimize side effects. Don't skip ahead! See the full semaglutide dosage chart for the complete schedule.
How to Manage Side Effects
The tips below address the most common GI symptoms. If side effects remain difficult to manage at lower doses, some users explore split dosing (microdosing), injecting the same weekly total in smaller, more frequent doses to reduce peak concentration and improve tolerability.
NAUSEA
- Eat smaller, more frequent meals
- Avoid fatty, greasy, or fried foods
- Stop eating when you feel full
- Ginger tea or ginger chews
- Don't lie down after eating
CONSTIPATION
- Increase fiber intake gradually
- Drink plenty of water (8+ glasses daily)
- Consider a fiber supplement like Metamucil
- Regular physical activity
DIARRHEA
- Avoid high-fat foods
- Limit artificial sweeteners
- Stay hydrated to replace fluids
- Consider probiotics
INJECTION TIPS
- Inject on the same day each week
- Evening injections may reduce daytime nausea
- Rotate injection sites
- Can inject with or without food
Serious Side Effects (Rare)
⚠️ While rare, seek immediate medical attention for:
Pancreatitis
- Severe abdominal pain that won't stop
- Pain radiating to your back
- Persistent nausea and vomiting
Gallbladder Problems
- Upper right abdominal pain
- Fever
- Yellowing of skin or eyes
Allergic Reactions
- Difficulty breathing
- Severe rash or itching
- Swelling of face/throat
Diabetic Retinopathy
- Vision changes
- Blurred vision
- Report to your doctor
Comparing Semaglutide Brands
How Semaglutide Side Effects Compare to Other GLP-1 Medications
Here's how semaglutide stacks up against tirzepatide (Mounjaro/Zepbound) and retatrutide (investigational triple agonist) on side effects and weight loss.
Semaglutide: Wegovy 2.4 mg (prescribing information, section 6.1 Table 3). Tirzepatide: Zepbound 5 to 15 mg (prescribing information, section 6.1 Table 1). Retatrutide: 12 mg group of the Phase 2 obesity trial (ClinicalTrials.gov NCT04881760); retatrutide has no FDA label, so these are trial data. The three come from separate trials with different populations, durations and placebo rates, so this is not a head-to-head comparison.
Semaglutide
Diarrhea 30% and constipation 24% at Wegovy 2.4 mg, though its placebo rates were also higher (16% and 11%), so cross-trial ranking is unreliable. Most clinical data. Only option with an oral form (the Ozempic and Rybelsus tablets for diabetes, and the Wegovy pill for weight).
Tirzepatide
Strong weight loss. Zepbound label nausea is 25-29% (placebo 8%).
Retatrutide
Highest efficacy (~24%) in Phase 2. Nausea at 12 mg was 45% in the small Phase 2 trial and 28% in the larger Phase 3 TRIUMPH-2 trial in adults with obesity and type 2 diabetes; no head-to-head results have been published (a retatrutide vs tirzepatide trial, TRIUMPH-5, is still running). Glucagon adds thermogenesis.
Related guides: Tirzepatide Side Effects · Retatrutide Side Effects
Who Should Be Cautious
Discuss with your doctor if you have:
Frequently Asked Questions
How long do Ozempic/Wegovy side effects last?
Most patients see significant improvement within 4-8 weeks. Side effects may temporarily return with dose increases but are usually milder than initial onset.
Are Rybelsus side effects different from Ozempic?
Both contain semaglutide with similar GI side effects. Rybelsus (oral) may cause slightly different absorption-related effects. The overall side effect profile is comparable at equivalent doses.
Why does Wegovy have more side effects than Ozempic?
Wegovy is dosed higher for weight loss (2.4mg recommended maintenance, up to a 7.2mg maximum, vs up to 2mg for Ozempic), and its label lists higher GI rates. The two labels come from different trial populations (adults with obesity or overweight vs adults with type 2 diabetes) with different placebo rates, so the figures are not directly comparable. The medication is identical.
Should I stop semaglutide if I have side effects?
Don't stop without consulting your provider. Most side effects are manageable and improve with time. Your provider may suggest dose adjustments or slower titration.
Bottom Line
Semaglutide side effects are common but manageable for most people:
- GI side effects are most common: nausea, diarrhea, vomiting, constipation
- Higher doses, higher label rates: Wegovy lists higher GI rates than Ozempic, though its trials also had higher placebo rates
- They usually improve: most patients adapt within 4-8 weeks
- Follow the escalation schedule: it exists to minimize side effects
- Dietary changes help: smaller meals, less fat, more water
Sources
- STEP 1 Trial (Wilding et al., NEJM 2021)
- SUSTAIN-6 Trial (Marso et al., NEJM 2016)
- Ozempic Prescribing Information, Novo Nordisk
- Wegovy Prescribing Information, Novo Nordisk (section 6.1 Table 3)
- Zepbound Prescribing Information, Eli Lilly (section 6.1 Table 1, for the comparison table)
- TRIUMPH-2 Phase 3 trial (The Lancet, 2026; adults with obesity and type 2 diabetes)
- Retatrutide Phase 2 posted results (ClinicalTrials.gov NCT04881760, adverse events)
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting or changing any medication.